Chargement en cours...
Predicting long‐term clinical stability in amyloid‐positive subjects by FDG‐PET
Imaging biomarkers can be used to screen participants for Alzheimer's disease clinical trials. To test the predictive values in clinical progression of neuropathology change (amyloid‐PET) or brain metabolism as neurodegeneration biomarker ([18F]FDG‐PET), we evaluated data from N = 268 healthy c...
Enregistré dans:
| Publié dans: | Ann Clin Transl Neurol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6562030/ https://ncbi.nlm.nih.gov/pubmed/31211176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.782 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|